AcuraBio has announced that it will provide a cGMP plasmid DNA contract development and manufacturing service using Cytiva’s new process platform technology.
AcuraBio partners with Cytiva to alleviate supply constraints for mRNA, cell and gene therapies
February 13, 2023 Australian Biotech
Latest Video
New Stories
-
PYC reports strong clinical momentum and cash position ahead of key readouts
October 27, 2025 - - Australian Biotech -
Government backs new national push to close bone health testing gap for women
October 27, 2025 - - Latest News -
Leadership change at PolyNovo as long-time Chair steps down
October 27, 2025 - - Australian Biotech -
Cann Group announces major debt restructure and capital raise to strengthen balance sheet
October 27, 2025 - - Australian Biotech -
FDA awards the first-ever national priority vouchers to nine sponsors
October 27, 2025 - - Latest News -
Cancer Australia looks to accelerate the delivery of national plan
October 27, 2025 - - Latest News -
Mark Butler announces the addition of another contraceptive option to the PBS
October 27, 2025 - - Latest News
